NCT00133146View on ClinicalTrials.gov

Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 12, 2005

Primary Completion Date

November 23, 2005

Study Completion Date

November 23, 2005

Conditions
Type I Hypersensitivity
Interventions
BIOLOGICAL

Grass MATA MPL

Trial Locations (1)

L4W 1N2

Allied Research International Inc., Mississauga

Sponsors
All Listed Sponsors
lead

Allergy Therapeutics

INDUSTRY